KRAS Promotes Tumor Metastasis and Chemoresistance by Repressing RKIP via the MAPK-ERK Pathway in Pancreatic Cancer

International Journal of Cancer - United States
doi 10.1002/ijc.31248
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

PEA15 Promotes Liver Metastasis of Colorectal Cancer by Upregulating the ERK/MAPK Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

LINC00978 Promotes Hepatocellular Carcinoma Carcinogenesis Partly via Activating the MAPK/ERK Pathway

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2020English

The Oncogene KRAS Promotes Cancer Cell Dissemination by Stabilizing Spheroid Formation via the MEK Pathway

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

MYH9 Promotes Growth and Metastasis via Activation of MAPK/AKT Signaling in Colorectal Cancer

Journal of Cancer
Oncology
2019English

CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway

PLoS ONE
Multidisciplinary
2016English

Hydrogen Peroxide Mediates Hyperglycemia-Induced Invasive Activity via ERK and P38 MAPK in Human Pancreatic Cancer

Oncotarget
Oncology
2015English

Leukemia-Related Protein 16 (LRP16) Promotes Tumor Growth and Metastasis in Pancreatic Cancer

OncoTargets and Therapy
OncologyPharmacology
2018English

TrkB Promotes Laryngeal Cancer Metastasis via Activation PI3K/AKT Pathway

Oncotarget
Oncology
2017English

miR-16 Regulates Proliferation and Invasion of Lung Cancer Cells via the ERK/MAPK Signaling Pathway by Targeted Inhibition of MAPK Kinase 1 (MEK1)

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy